{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:22:40Z","timestamp":1777533760238,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.schres.2015.01.044","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T15:53:36Z","timestamp":1424188416000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["ACE I\/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone"],"prefix":"10.1016","volume":"164","author":[{"given":"Ary","family":"Gadelha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila M.","family":"Yonamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa K.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Ricardo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sintia I.","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo A.","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian A.F.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2015.01.044_bb0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410320306","article-title":"Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia","volume":"32","author":"Allen","year":"1992","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.schres.2015.01.044_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2015.01.044_bb0015","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0006-3223(95)00597-8","article-title":"An insertion\/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders","volume":"40","author":"Arinami","year":"1996","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2015.01.044_bb0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM197903013000921","article-title":"Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophrenia","volume":"300","author":"Arregui","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.schres.2015.01.044_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.fbp.0000224382.63744.20","article-title":"Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task","volume":"17","author":"Azmi","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.schres.2015.01.044_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phrs.2013.07.004","article-title":"Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors","volume":"76","author":"Bali","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.schres.2015.01.044_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/gtmb.2010.0064","article-title":"Investigation of association between Angiotensin-converting enzyme gene insertion\/deletion polymorphism frequency in Turkish patients with schizophrenia","volume":"14","author":"Baskan","year":"2010","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"6","key":"10.1016\/j.schres.2015.01.044_bb0040","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/hy1201.101214","article-title":"History about the discovery of the renin-angiotensin system","volume":"38","author":"Basso","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.schres.2015.01.044_bb0045","first-page":"679","article-title":"Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics","volume":"19","author":"Beckmann","year":"1984","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.044_bb0050","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/nprot.2006.306","article-title":"A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay","volume":"1","author":"Carmona","year":"2006","journal-title":"Nat. Protoc."},{"issue":"1\u20132","key":"10.1016\/j.schres.2015.01.044_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.psychres.2008.04.024","article-title":"Insertion\/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population","volume":"165","author":"Crescenti","year":"2009","journal-title":"Psychiatry Res."},{"issue":"8","key":"10.1016\/j.schres.2015.01.044_bb0060","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/HJH.0b013e32833af3b2","article-title":"Brain angiotensin peptides regulate sympathetic tone and blood pressure","volume":"28","author":"Dupont","year":"2010","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.schres.2015.01.044_bb0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpsychires.2013.01.009","article-title":"Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia-a potential biomarker?","volume":"47","author":"Gadelha","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.schres.2015.01.044_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002881","article-title":"Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia","volume":"3","author":"Gao","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.schres.2015.01.044_bb0075","first-page":"70","article-title":"Insertion-deletion polymorphism of angiotensin-1-converting enzyme gene in patients with endogenic psychoses","volume":"105","author":"Golimbet","year":"2005","journal-title":"Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova"},{"issue":"10","key":"10.1016\/j.schres.2015.01.044_bb0080","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1073\/pnas.0500330102","article-title":"Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1","volume":"102","author":"Hayashi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.schres.2015.01.044_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/1516-4446-2013-1330","article-title":"Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil \u2014 convergent validation of the Brazilian version","volume":"36","author":"Higuchi","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"10","key":"10.1016\/j.schres.2015.01.044_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia is a cognitive illness: time for a change in focus","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2015.01.044_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the renin\u2013angiotensin system a new treatment option for Alzheimer's disease?","volume":"6","author":"Kehoe","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.schres.2015.01.044_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/YPG.0b013e3283351194","article-title":"Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives","volume":"20","author":"Kucukali","year":"2010","journal-title":"Psychiatr. Genet."},{"issue":"5","key":"10.1016\/j.schres.2015.01.044_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/YPG.0b013e3283518524","article-title":"Angiotensin-converting enzyme gene insertion\/deletion polymorphism is not associated with schizophrenia in a Croatian population","volume":"22","author":"Nadalin","year":"2012","journal-title":"Psychiatr. Genet."},{"issue":"92-3","key":"10.1016\/j.schres.2015.01.044_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tox.2008.06.005","article-title":"Protective effect of captopril and enalaprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced *OH generation and dopamine efflux in rat striatum","volume":"250","author":"Obata","year":"2008","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.schres.2015.01.044_bb0130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.schres.2015.01.044_bb9000","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1590\/S0100-879X2000000700005","article-title":"Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats","volume":"33","author":"Oliveira","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.01.044_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000054911","article-title":"Association study of angiotensin-converting enzyme gene polymorphism with schizophrenia and polydipsia","volume":"44","author":"Ouyang","year":"2001","journal-title":"Neuropsychobiology"},{"issue":"12","key":"10.1016\/j.schres.2015.01.044_bb0140","doi-asserted-by":"crossref","first-page":"e83340","DOI":"10.1371\/journal.pone.0083340","article-title":"High-throughput sequencing of a South American Amerindian","volume":"8","author":"Ribeiro-dos-Santos","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.schres.2015.01.044_bb0145","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.schres.2015.01.044_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.10255","article-title":"Angiotensin converting enzyme gene insertion\/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia","volume":"114","author":"Segman","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.schres.2015.01.044_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/1470320313495909","article-title":"The insertion\/deletion polymorphism in the angiotensin-converting enzyme and susceptibility to schizophrenia or Parkinson's disease: A meta-analysis","author":"Song","year":"2014","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"1","key":"10.1016\/j.schres.2015.01.044_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0920-9964(93)90013-9","article-title":"Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients","volume":"9","author":"Wahlbeck","year":"1993","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.01.044_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/oxfordjournals.schbul.a033334","article-title":"Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia","volume":"24","author":"Wahlbeck","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2015.01.044_bb0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0920-9964(99)00059-6","article-title":"Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia","volume":"41","author":"Wahlbeck","year":"2000","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.01.044_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin\u2013angiotensin\u2014a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2015.01.044_bb0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A role for the brain RAS in Alzheimer's and Parkinson's Diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.schres.2015.01.044_bb0185","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2011.09.016","article-title":"Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats","volume":"1421","author":"Yamada","year":"2011","journal-title":"Brain Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:49:54Z","timestamp":1566348594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":35,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0920996415000742"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.01.044","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACE I\/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.01.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}